Skip to main content

Table 1 Characteristics of study participants at baseline by randomised treatment

From: Genetic predisposition scores for dyslipidaemia influence plasma lipid concentrations at baseline, but not the changes after controlled intake of n-3 polyunsaturated fatty acids

 

Placebo

0.45 g/day

0.9 g/day

1.8 g/day

P*

n = 70

n = 80

n = 80

n = 80

Gender

 Male, n (%)

31, 44

30, 37.5

30, 37.5

29, 36

 

 Female, n (%)

39, 56

50, 62.5

50, 62.5

51, 64

 

Ethnicity

 White, n (%)

57, 81.4

64, 80.0

64, 80.0

69, 86.25

 

 Far Eastern, n (%)

6, 8.6

4, 5.0

5, 6.25

1, 1.25

 

 S. Asian, n (%)

3, 4.3

6, 7.5

8, 10.0

1, 1.25

 

 Black, n (%)

2, 2.85

3, 3.75

0, 0.0

4, 5.0

 

 Other, n (%)

2, 2.85

3, 3.75

3, 3.75

5, 6.25

 

Age (years)

55.4 ± 6.9

55.1 ± 6.8

55.2 ± 6.6

55.1 ± 6.7

0.99

BMI (kg/m2)

26.1 ± 3.7

25.1 ± 3.9

26.2 ± 4.0

25.2 ± 3.5

0.17

Waist circumference (cm)

89.5 ± 11.7

87.3 ± 11.8

89.4 ± 11.9

88.0 ± 11.0

0.60

Plasma lipids (mmol/L)

 TC

5.4 ± 1.0

5.4 ± 1.1

5.4 ± 0.9

5.4 ± 1.0

0.94

 HDL-C

1.6 ± 0.5

1.6 ± 0.4

1.7 ± 0.5

1.7 ± 0.5

0.26

 LDL-C

3.3 ± 0.8

3.2 ± 0.8

3.2 ± 0.8

3.2 ± 0.7

0.79

 TGa

1.2 ± 0.5

1.1 ± 0.5

1.1 ± 0.4

1.1 ± 0.5

0.96

  1. Data are presented for subjects randomised to treatment groups for whom DNA was available (n = 310). Measurements taken at baseline after 4-week run-in on normal diet with olive oil placebo supplement are shown for each randomised treatment group: placebo and EPA and DHA (1.51:1) at the daily doses shown. Values are n (%) for gender and ethnic groups, or mean ± SD for all other variables except TG
  2. BMI body mass index, HDL-C high-density-lipoprotein cholesterol, LDL-C low-density-lipoprotein cholesterol, TC total cholesterol, TG triglyceride
  3. * Significance of differences between treatment groups assessed by one-way ANOVA. P value for difference in age, adjusted for BMI, gender and ethnicity; for differences in BMI and waist circumference, adjusted for age, gender and ethnicity; for differences in plasma lipid concentrations, adjusted for BMI, age, gender and ethnicity
  4. aTG data not normally distributed and presented as the geometric mean ± SE